Sonoma Pharmaceuticals, Inc. SNOA Q1 2026 Annual earnings

FAQ

When did Sonoma Pharmaceuticals, Inc. report Q1 2026 earnings?

Sonoma Pharmaceuticals, Inc. (SNOA) reported Q1 2026 earnings on June 16, 2026 before market open.

What were Sonoma Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?

Sonoma Pharmaceuticals, Inc. reported revenue of $5.6M and eps of $-0.09 for Q1 2026.

Did Sonoma Pharmaceuticals, Inc. beat estimates in Q1 2026?

Revenue missed the consensus estimate of $5.6M by $4.3K. EPS beat the consensus estimate of $-0.24 by $0.15.

How did Sonoma Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 48.1% from $3.8M a year earlier and eps grew 40.0% from $-0.15.

Where can I find Sonoma Pharmaceuticals, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001683168-26-004975) and the 10-K periodic report (0001683168-26-004871) directly on SEC EDGAR. The filing index links above go to sec.gov.